110 related articles for article (PubMed ID: 2335266)
1. Abdominal carcinoid tumours in Sheffield.
Woods HF; Bax ND; Ainsworth I
Digestion; 1990; 45 Suppl 1():17-22. PubMed ID: 2335266
[TBL] [Abstract][Full Text] [Related]
2. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
Kinney MA; Warner ME; Nagorney DM; Rubin J; Schroeder DR; Maxson PM; Warner MA
Br J Anaesth; 2001 Sep; 87(3):447-52. PubMed ID: 11517130
[TBL] [Abstract][Full Text] [Related]
3. Sandostatin and carcinoid tumours in France: experience in the Lyon area.
Chayvialle JA
Digestion; 1990; 45 Suppl 1():23-6. PubMed ID: 1692295
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide.
Oberg K; Norheim I; Theodorsson E
Acta Oncol; 1991; 30(4):503-7. PubMed ID: 1854508
[TBL] [Abstract][Full Text] [Related]
6. Development of effective prophylaxis against intraoperative carcinoid crisis.
Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.
Quaedvlieg PF; Visser O; Lamers CB; Janssen-Heijen ML; Taal BG
Ann Oncol; 2001 Sep; 12(9):1295-300. PubMed ID: 11697843
[TBL] [Abstract][Full Text] [Related]
8. [Multiple carcinoid tumors of the small intestine].
Tordjmann T; Fléjou JF; Ruszniewski P; Belghiti J; Bernades P
Gastroenterol Clin Biol; 1995 May; 19(5):534-6. PubMed ID: 7590007
[TBL] [Abstract][Full Text] [Related]
9. Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatin.
Vinjamaram S; Iyer R
Cancer Chemother Pharmacol; 2011 Jul; 68(1):225-6. PubMed ID: 20922390
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid tumours and the role of Sandostatin.
Woods HF
NATNEWS; 1989 Jul; 26(7):13-5. PubMed ID: 2779638
[No Abstract] [Full Text] [Related]
11. [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
Okabe N; Inoue T; Watanabe Y; Muto S; Hasegawa T; Ohsugi J; Higuchi M; Shio Y; Suzuki H
Gan To Kagaku Ryoho; 2014 Jul; 41(7):879-83. PubMed ID: 25131876
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
Stöckmann F; Creutzfeldt W
Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
[TBL] [Abstract][Full Text] [Related]
13. Sandostatin and the Belfast experience.
Buchanan KD; Collins JS; Varghese A; Johnston CF; Shaw C
Digestion; 1990; 45 Suppl 1():11-4; discussion 15-6. PubMed ID: 2159429
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
15. [Symptomatic treatment of the malignant carcinoid syndrome with octreotide].
Alberts AS; Falkson G
S Afr Med J; 1989 Jan; 75(1):30-1. PubMed ID: 2911781
[TBL] [Abstract][Full Text] [Related]
16. Effects of sandostatin on neuroendocrine tumours of the gastrointestinal system.
Buchanan KD
Recent Results Cancer Res; 1993; 129():45-55. PubMed ID: 8394596
[TBL] [Abstract][Full Text] [Related]
17. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
[TBL] [Abstract][Full Text] [Related]
18. Management of disseminated midgut carcinoid tumours.
Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
[TBL] [Abstract][Full Text] [Related]
19. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
Massimino K; Harrskog O; Pommier S; Pommier R
J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
[TBL] [Abstract][Full Text] [Related]
20. Carcinoid syndrome.
Zambrzycki JK; Elliott CG
Nurse Anesth; 1993 Dec; 4(4):198-201. PubMed ID: 7907889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
